(Q39435738)

11 September 2017

Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer (English)

1 reference

11 September 2017

0 references

1 reference

1 reference

Haitao Yin

1

1 reference

11 September 2017

Rui Guo

2

1 reference

11 September 2017

Yong Xu

3

1 reference

11 September 2017

Yulong Zheng

4

1 reference

11 September 2017

Zhibo Hou

5

1 reference

11 September 2017

Xinzheng Dai

6

1 reference

11 September 2017

Zhengdong Zhang

7

1 reference

11 September 2017

Donghui Zheng

8

1 reference

11 September 2017

Hua'e Xu

9

1 reference

11 September 2017

language of work or name

1 reference

29 November 2011

1 reference

Acta Biochimica et Biophysica Sinica

11 September 2017

1 reference

11 September 2017

44

1 reference

11 September 2017

2

1 reference

11 September 2017

147-153

1 reference

11 September 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Docetaxel in the treatment of advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Chemopreventive and therapeutic effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Chemosensitization and radiosensitization of tumors by plant polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

Resistance to paclitaxel is proportional to cellular total antioxidant capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR106

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMR106

1 reference

11 September 2017

1 reference